European Commission
Ginkgo Bioworks, TGen, Partners Land €24M European Grant to Develop NGS-Based POC Respiratory Test
The consortium is built around a technology collaboration between Jumpcode and TGen that uses CRISPR-based targeted metagenomic sequencing to detect pathogens.
Illumina to Spin off Grail by Issuing Shares to Investors, Will Keep 14.5 Percent
Illumina shareholders will receive one share of Grail for every six shares of Illumina stock, with cash issued in lieu of fractional shares.
While Eudamed is at the center of Europe's new IVD Regulation, its rollout has taken longer than expected, and only some of its modules are currently operational and have been tested.
European Parliament Agrees to Give IVD Firms More Time to Comply With IVDR Under Certain Conditions
The European Commission had proposed moving back certain IVDR deadlines after finding some IVDs didn't meet the rules, which started rolling out in 2022.
European Commission Approves Illumina's Plan for Divesting Grail
Whether Illumina will sell Grail to another firm or pursue a capital markets transaction such as an initial public offering is yet to be determined.